Is ROMIPLATE 250 ug INJECTION approved by KKM / NPRA in Malaysia?

Yes, ROMIPLATE 250 ug INJECTION is officially registered with the National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health Malaysia under registration number MAL20112174AZ with status "PRODUCT APPROVED".

What are the generic alternatives for ROMIPLATE 250 ug INJECTION in Malaysia?

There are 1 approved pharmaceutical formulations registered in Malaysia containing the same active ingredient (Romiplostim), which can be compared for cost and availability.

MAL20112174AZPrescription (MAL-A)

ROMIPLATE 250 ug INJECTION

Q: What are the active ingredients of ROMIPLATE 250 ug INJECTION?

The active ingredients of ROMIPLATE 250 ug INJECTION as declared to NPRA are: ROMIPLOSTIM 250mcg.

Generic Molecule: Romiplostim

ACTIVE & APPROVEDValid till: 24 Nov 2026

NPRA Official Regulatory Summary

ROMIPLATE 250 ug INJECTION is a KKM-approved Prescription Medicine registered under MAL number MAL20112174AZ by DKSH MALAYSIA SDN. BHD.. Its active ingredient is ROMIPLOSTIM 250mcg, manufactured by Kyowa Kirin Co., Ltd., Takasaki Plant.

Holder (PRH)

DKSH MALAYSIA SDN. BHD.

Manufacturer

Kyowa Kirin Co., Ltd., Takasaki Plant

First Registered

24 Nov 2021

Validity

24 Nov 2026

Prescription Required (Schedule Poison)

Need a valid doctor's prescription renewal in Malaysia?

Consult Online Doctor (Telehealth)

Active Ingredients & Strength Formulation

1 Component

Active Substance / Molecule	Declared Strength / Dosage	Generic Directory
ROMIPLOSTIM	250mcg	Find Brands

Dosage values indicate declared active concentration per unit dose as registered with NPRA Malaysia.

Sole Registered Brand Formulation

This product is currently the primary or innovator formulation registered in Malaysia under Romiplostim.

Malaysian KKM Security Hologram Verification

FarmaChecker & Meditag™

By Malaysian Ministry of Health (KKM) regulation, all genuine registered pharmaceuticals, health supplements (MAL-N), and traditional products (MAL-T) distributed in Malaysia must feature an official tamper-evident security hologram sticker on the physical packaging.

1. Visual Tilt Check

Tilt the box under light to view the micro-engraved KKM coat of arms and multi-layer iridescent security patterns.

2. Match MAL Number

Ensure the printed MAL code matches MAL20112174AZ exactly on label and box.

3. FarmaChecker Scan

Scan using the official FarmaChecker app on iOS / Android to authenticate serial token with NPRA servers.

If the packaging lacks a security hologram or fails the FarmaChecker scan, do not consume and report to Cawangan Penguatkuasaan Farmasi (CPF KKM).

Frequently Asked Questions & Verification Details

Is ROMIPLATE 250 ug INJECTION approved by KKM / NPRA?

Yes. ROMIPLATE 250 ug INJECTION is actively registered with the National Pharmaceutical Regulatory Agency under official registration number MAL20112174AZ with current status PRODUCT APPROVED. Registration was filed by DKSH MALAYSIA SDN. BHD..

What are the active ingredients of ROMIPLATE 250 ug INJECTION?

The declared active therapeutic components are: ROMIPLOSTIM 250mcg. Always follow dosage recommendations prescribed by a certified doctor or licensed pharmacist.

What are the registered generic alternatives in Malaysia?

In Malaysia, there are 1 registered brand formulations containing identical active ingredients (Romiplostim). You can review them in the alternative brands section above or consult your community pharmacist for generic bioequivalent substitution.

Semakan status pendaftaran KKM / NPRA: ROMIPLATE 250 ug INJECTION (MAL20112174AZ) | Pengganti ubat di Malaysia | Bahan aktif ubat & maklumat farmasi.